000 01771 a2200493 4500
005 20250516155412.0
264 0 _c20140204
008 201402s 0 0 eng d
022 _a1875-8894
024 7 _a10.3233/PRM-130242
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCohran, Valeria
245 0 0 _aOral risedronate sodium improves bone mineral density in non-ambulatory patients: a randomized, double-blind, placebo controlled trial.
_h[electronic resource]
260 _bJournal of pediatric rehabilitation medicine
_c2013
300 _a85-93 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAbsorptiometry, Photon
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAlkaline Phosphatase
_xblood
650 0 4 _aBiomarkers
_xblood
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Density Conservation Agents
_xadministration & dosage
650 0 4 _aCerebral Palsy
_xpathology
650 0 4 _aChild
650 0 4 _aCollagen Type I
_xblood
650 0 4 _aDouble-Blind Method
650 0 4 _aEtidronic Acid
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLumbar Vertebrae
_xdiagnostic imaging
650 0 4 _aMale
650 0 4 _aOsteocalcin
_xblood
650 0 4 _aPeptides
_xblood
650 0 4 _aRisedronic Acid
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aCassedy, Amy
700 1 _aHawkins, Andre
700 1 _aBean, Judy
700 1 _aHeubi, James
773 0 _tJournal of pediatric rehabilitation medicine
_gvol. 6
_gno. 2
_gp. 85-93
856 4 0 _uhttps://doi.org/10.3233/PRM-130242
_zAvailable from publisher's website
999 _c22869074
_d22869074